Charles River Labs Intl buy Wells Fargo & Company
Start price
22.09.23
/
50%
€188.80
Target price
22.09.24
€257.73
Performance (%)
-1.59%
End price
23.09.24
€185.80
Summary
This prediction ended on 23.09.24 with a price of €185.80. With a performance of -1.59%, the BUY prediction by Wells_Fargo___Compan finished with a loss. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Charles River Labs Intl | 0.949% | 0.949% | -6.080% |
| iShares Core DAX® | -0,48 % | -12,06 % | -2,95 % |
| iShares Nasdaq 100 | -3,38 % | -5,13 % | 9,58 % |
| iShares Nikkei 225® | -0,14 % | -12,63 % | 20,32 % |
| iShares S&P 500 | -2,27 % | -5,05 % | 5,80 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at Wells Fargo & Company from $280.00 to $275.00. They now have an "overweight" rating on the stock.
Ratings data for CRL provided by MarketBeat
In the thread Trading Charles River Labs Intl
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten